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Abstract
Recently, Korean people are consuming seaweeds almost 3.5 times more now than three decades ago. It is well known that seaweeds contain
lots of soluble dietary fiber in addition to micronutrients such as β-carotene, iodine and some bioactive components. Seaweeds are considered to 
be effective for preventing chronic diseases including obesity, diabetes mellitus, atherosclerosis, cancer or constipation. This study was conducted
to investigate the effect of seamustard intake on body weight gain, blood glucose level and lipid profiles in rats fed diets with different energy
nutrient composition. Male Sprague-Dawley rats (average initial weight 103.7 g) were divided into groups for two experiments as follows; Control, 
M2.5 & M5 groups (Exp. I) and M5, M10, HCM5, HCM10, HFM5 & HFM10 groups (Exp. II). The rats were fed diet and water ad libitum
for 4 weeks. In general, there was no significant difference in blood glucose and triglyceride concentration among groups. In Exp. I, serum LDL-cholesterol 
level of rats fed diet with 5% seamustard powder (M5) was significantly lower than that of control group, while HDL-cholesterol level, TC/LDL
ratio and weight of adrenal gland were higher. In Exp. II, food intake, body weight gain and EER of high fat diet with 10% seamustard group
(HFM10) were the lowest among groups. Except gastrocnemius muscle, all organ weights of HFM10 group were the lowest. Fecal cholesterol excretion
and serum LDL-cholesterol concentration of HFM10 group were the highest, while serum HDL-cholesterol level was the lowest among groups.
Interestingly, HDL-cholesterol concentration was the highest in HCM5 group among groups. From these results, it was suggested that seamustard 
intake might be more effective for body weight control, but not for improving blood lipid profiles in high fat diet than in high carbohydrate diet.
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Introduction5)
According to the third National Health and Nutrition Survey 
(Ministry of Health and Welfare, 2006), Korean consumed more 
animal foods and less plant foods during the past 30 years. However, 
the consumption of seaweeds such as sea tangle, seamustard, and 
sea lettuce has continued to increase 3.5 times from 2.4 g/d in 
1970 to 8.5 g/d in 2005. Traditionally, many postpartum women 
in Korea have used a seamustard soup in order to return to the 
pre-pregnant state physiologically as fast as possible. According 
to Donguibogam written by Heo Jun who was the famous doctor 
in the Joseon Dynasty, seamustard was used to stimulate the 
excretion or removal of watery components after delivery (Choi, 
2003). Nowadays marine natural products are considered to be 
effective for preventing chronic diseases such as obesity, diabetes 
mellitus, atherosclerosis, cancer as well as constipation (BFN, 
2005). Various seaweeds contain lots of alginic acid, in addition 
to beta carotene, iodine or bioactive components such as fucoidan. 
Among them, alginic acid, a kind of soluble viscous fiber, is 
one of the important healthy components. One of its well-known 
physiological functions is a LDL cholesterol-lowering effect 
(Anderson & Hanna, 1999; Fernandez, 2001). 
Hypertriglyceridemia and cholesterolemia seem to confer a 
higher risk of atherosclerotic cardiovascular disease in diabetic 
person than non-diabetics (Hu et al., 2001; Rubins et al., 1999). 
Including animal fat and trans-fatty acid, dietary modification 
of protein, carbohydrate, fiber or phytosterol could affect cholesterol 
metabolism. Recently, a low fat and high carbohydrate diet is 
considered to protect against heart disease. However, the fasting 
triglyceride level would be increased if there were no dietary 
fiber in high carbohydrate diet (Robins et al., 2003). 
This study was conducted to investigate the effects of seamustard 
powder on body weight change, blood glucose concentration and 
lipid profiles in rats fed diet with different energy nutrient composition.
Materials and Methods
Animals and diets
Male Sprague-Dawley rats (average initial weight 103.7 g, 
n=48) were divided into eight groups as follows: Control diet, 
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Table 1. Dietary composition of groups in Exp. I (g/kg diet)
Components
Experiment Groups
1)
Control M2.5 M5
Starch 400.684
Casein 250.0
Fat+oil* 150.0
Sucrose 100.0
Mineral mixure
 2) 35.0
Vitamin mixture
 3) 10.0
L-cystine 1.8
t-Butylhydroquinone 0.016
Choline bitartrate 2.5
Cellulose 50.0 25.0 -
Seamustard - 25.0 50.0
Total 1000  1000  1000
1)  All  diets  were  based  on  AIN  -93G  diet.
M2.5 : control diet with 2.5% seamustard powder as fiber source (4.67 kcal/g)
M 5  :  c o n t r o l d ie t  w it h  5 %  s e a m u s t a r d  p o w d e r  a s  f i b e r  s o u r c e  ( 4 .70  kcal/g)
2) Mineral mixture :  calcium carbonate  (35.7%), potassium phosphate monobasic 
(25.0%), potassium citrate monohydrate (2.8%), sodium chloride (7.4%), potassium 
sulfate (4.66%), magnesium oxide (2.43%), ferric citrate (0.606%), zinc carbonate 
(0.165%), manganous carbonate (0.063%), cupric carbonate (0.031%), potassium 
iodate (0.001%), sodium selenate (0.001%), ammonium paramolybdate (0.001%), 
sodium  metasillicate  (0.145%),  chromium  potassium  sulfate  (0.028%),  lithium 
chloride (0.002%), boric acid (0.008%), sodium fluoride (0.006%), nickel carbonate 
hydroxide  tetrahydrate  (0.003%),  ammonium  vanadate  (0.001%)  and s u c r o s e  
(20.95%)
3) Vitamin mixture : nicotinic acid (0.3%), calcium pantothenate (0.16%), pyridoxine- 
HCl (0.07%), thiamin HCl (0.06%), riboflavin (0.06%), folic acid (0.02%), D-biotin 
(0.002%), Vit B12 in 0.1% mannitol (0.25%), DL-a-tocopherol acetate, 500 IU/g 
(1.50%),  retinol  palmitate,  500,000  IU/g  (0.08%),  Vit  D3  (50,000 IU/g) (0.02%), 
V i t  K  ( 0 . 0 0 7 % )  a n d  s u c r o s e  ( 9 7 . 4 7 % )
*  l a r d  :  s o y b e a n  o i l=1 : 1  ( w / w ) 
Table 2. Dietary composition of groups in Exp. II (g/kg diet)
Components
Experiment Groups
1)
M5 M10 HCM5 HCM10 HFM5 HFM10
Starch 400.684 350.684 625.684 575.684 300.684 250.684
Casein 250.0 250.0 120.0 120.0 120.0 120.0
Fat+oil* 150.0 150.0 75.0 75.0 280.0 280.0
Sucrose 100.0 100.0 80.0 80.0 200.0 200.0
Mineral mixture
 2) 35.0
Vitamin mixture
 3) 10.0
L-cystine 1.8
t-Butylhydroquinone 0.016
Choline bitartrate 2.5
Seamustard 50.0 100.0 50.0 100.0 50.0 100.0
Total 1000 1000 1000 1000 1000 1000
1) All  diets  were  based  on  AIN  -93G  diet. 
M5  :  control  diet  with  5%  seamustard  powder  as  fiber  source  (4.70  kcal/g)
M10  :  control  diet  with  10%  seamustard  powder  as  fiber  source  (4.67  kcal/g)
HCM5 : high carbohydrate diet with 5% seamustard powder as fiber source (4.34 
kcal/g)
HCM10:  high  carbohydrate  diet  with  10%  seamustard  powder  as  fiber  source 
(4.26  kcal/g)
H F M 5 : h ig h  fa t  d ie t  w ith  5 %  s e a m u s ta rd  p o w d e r a s  fib e r s o u rc e  (5.67  kcal/g)
HFM10: high fat diet with 10% seamustard powder as fiber source (5.53 kcal/g)
2)-3)  See  Table  1.
*l a r d  :  s o y b e a n  o i l =  1 : 1  ( w / w ) 
M2.5 (2.5% seamustard diet), M5 (5% seamustard diet), M10 
(10% seamustard diet), HCM5 (high carbohydrate+5% seamustard 
diet), HCM10 (high carbohydrate+10% seamustard diet), HFM5 
(high fat+5% seamustard diet) and HFM10 (high fat+10% 
seamustard diet). In fact, two experiments were designed 
concomitantly. Experiment I was consisted of three groups 
(control, M2.5 & M5) according to the level of seamustard 
powder in control diet. Experiment II was consisted of six groups 
(M5, M10, HCM5, HCM10, HFM5 & HFM10) according to 
seamustard level and dietary energy composition. All diets were 
based on AIN-93G diet (Reeves, 1997) as shown Table 1. All 
ingredients of diets were purchased from Labanimal Co. (Dyets, 
Bethleham, PA). Total experiment period was 4 weeks. The 
animals were fed diet and tap water ad libitum with alternating 
12-h light/12-h dark cycle in temperature controlled (20-22℃) 
room at a relative humidity (50-60%). From the food intake and 
body weight gain of rats, food efficiency ratio (FER) and energy 
efficiency ratio (EER) were calculated. For three days a week, 
feces were collected and weighed immediately and stored at -20℃ 
in the refrigerator. All animal procedures conformed to “Guide 
for the Care and Use of Laboratory Animals” (National Research 
Council, 1996).
Sample collection and biochemical analysis
The blood samples were collected from the carotid of rats 
anesthetized with ethyl ether. Samples were then centrifuged at 
3,000 rpm for 20 minutes and the serum was separated. The 
organs such as liver, spleen, kidneys, adrenal glands, epididymal 
fat pads and gastrocnemius muscle were removed and weighed 
immediately. All samples were stored at -70℃ until analysis. 
The concentrations of total- and HDL-cholesterol, triglyceride 
and glucose in serum were determined enzymatically by using 
commercial kit (Asan Pharmaceutical, Seoul, Korea). Serum 
LDL-cholesterol level was calculated from the equation of 
Friedewald et al. (1972). The total lipid contents in liver and 
feces were extracted with chloroform: methanol mixture (v/v, 
2:1) and measured using the method of Bligh and Dyer (1959). 
Hepatic and fecal cholesterol concentrations in the lipid extracts 
were measured enzymatically by using commercial kit (Asan 
Pharmaceutical, Seoul, Korea). 
Statistical analysis
All data were expressed as mean ± SD. The significance of 
difference among groups was determined by one way analysis 
of variance (ANOVA) using the SPSS program v.14 (SPSS, 
Chicago, IL, USA). The result was considered to be significantly 
different if the p value was <.05, and then Duncan’s multiple 
range test was performed if differences were identified among 
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Table 3. Food intakes, body weight and body weight gain of rats in Exp. I
Experiment Groups Food Intakes
(g/4 wks)
Energy Intakes
(kcal/4 wks)
Final BW
(g)
BW Gain
(g/4 wks) FER EER
Control 64.5 ± 4.4
1)N.S. 299.9 ± 20.5
ab2) 256.8 ± 17.7
N.S. 152.8 ± 11.7
N.S. 2.38 ± 0.28
N.S. 0.51 ± 0.06
N.S.
M2.5 68.8 ± 5.5 321.7 ± 25.5
a 281.6 ± 30.8 177.7 ± 31.0 2.59 ± 0.45 0.55 ± 1.21
M5 59.1 ± 7.6 277.9 ± 20.5
b 254.0 ± 35.0 150.0 ± 33.4 2.51 ± 0.34 0.54 ± 0.09
1)  Mean ± SD
2)  Significantly  different  among  groups  by  Duncan’s  multiple  range  test  at  a=0.05  level  after  one  way  ANOVA.
N.S.  no  significant  difference
BW  body  weight
FER  (food  efficiency  ratio) = body  weight  gain/food  intakes
EER  (energy  efficiency  ratio) = body  weight  gain/energy  intakes
Table 4. Organ weights of rats in Exp. I (g)
Experiment Groups Liver Spleen Kidney Adrenal gland Epidedymal Fat pad Gastrocnemius 
Control 8.48 ± 1.22
1)N.S 0.46 ± 0.10
N.S. 2.05 ± 0.28
N.S. 0.024 ± 0.007
b2) 2.10 ± 0.46
b 2.78 ± 0.94
N.S.
M2.5 9.58 ± 1.20 0.59 ± 0.14 2.12 ± 0.19 0.030 ± 0.015
ab 2.81 ± 0.80
a 2.04 ± 0.94
M5 8.39 ± 1.87 0.55 ± 0.13 2.19 ± 0.26 0.046 ± 0.024
a 2.01 ± 0.32
b 2.58 ± 0.86
1)  Mean ± SD
2)  Significantly  different  among  groups  by  Duncan’s  multiple  range  t e s t  a t  a = 0 . 0 5   le v e l  a f t e r  o n e  w a y  A N O V A .
N.S.  no  significant  difference
Table 5. Fecal lipid and hepatic lipid contents of rats Exp. I
Experiment Groups Fecal Weight*
(g)
Fecal Lipid 
(g/g feces)
Fecal Cholesterol
(mg/g feces)
Hepatic Lipid 
(g/g tissue)
Hepatic Cholesterol 
(mg/g tissue)
Control 18.58 ± 2.26
1)N.S 0.081 ± 0.019
N.S. 6.05 ± 0.85
N.S. 0.110 ± 0.018
N.S. 62.19 ± 5.93
N.S.
M2.5 17.48 ± 4.96 0.086 ± 0.016 7.80 ± 1.32 0.111 ± 0.031 80.02 ± 28.34
M5 12.75 ± 3.37 0.116 ± 0.023 6.32 ± 1.87 0.126 ± 0.039 59.27 ± 7.63
1)  Mean ± SD
N.S.  no  significant  difference
* The  feces  were  collected  from  3  week  to  4  week  during  experimental  periods.
Table 6. Serum glucose concentration and lipid profile of rats in Exp. I
Experiment Groups Serum Glucose 
Concentration (mg/dl)
Serum Lipid Concentration
TG (mg/dl) TC (mg/dl) LDL (mg/dl) HDL (mg/dl)
Control 119.31 ± 23.26
1)N.S. 19.45 ± 9.10
N.S. 70.32 ± 13.04
N.S. 51.44 ± 14.14
a2) 14.98 ± 7.82
b
M2.5 119.34 ± 10.98 25.90 ± 3.67 77.02 ± 18.18 45.45 ± 18.42
a 26.38 ± 7.03
a
M5 118.63 ± 24.12 25.84 ± 24.01 64.31 ± 11.34 36.16 ± 8.95
b 22.98 ± 3.43
ab
1)  Mean ± SD
2) S i g n i f i c a n t l y  d i f f e r e n t  a m o n g  g r o u p s  b y  D u n c a n ’s  multiple  range  test  at  a=0.05  level  after  one  way  ANOVA.
N.S.  no  significant  difference
Results 
Exp. I
The food and energy intake, body weight gain, food efficiency 
ratio (FER) and energy efficiency ratio (EER) of rats are shown 
in Table 3. Energy intake of M5 group was the lowest among 
groups. However, food intakes, body weight and body weight 
gain were not significantly different among groups. Consequently, 
there were no significant differences in FER and EER among 
groups according to seamustard level.
As shown in Table 4, for weights of liver, spleen, kidney and 
gastrocnemius muscle there were no significant differences 
among three groups. However, seamustard intake resulted to 
affect the weights of epididymal fat pads and adrenal glands 
(p<.05). Adrenal glands weight of M5 group was the highest, 
but the weight of epididymal fat pads was significantly lower 
than that of M2.5 group (p<.05). 
As shown in Table 5, all of daily fecal excretion, fecal lipid 
and cholesterol contents, hepatic lipid and cholesterol contents 
did not show any significant differences among groups according 
to seamustard level.
The serum concentrations of glucose, triglyceride and total 
cholesterol (TC) did not show any significant differences among 
three groups. Interestingly, serum LDL-cholesterol (LDL) 
concentration of M5 group was the lowest among groups. 
However, serum HDL-cholesterol concentrations of M2.5 and 
M5 groups were higher than that of control group (Table 6). 
Collectively shown in Table 7, the ratios of TC / LDL of M2.5 
and M5 groups were significantly higher than that of control 34 Seamustard, energy composition & blood lipid profiles
Table 7. The risk for cardiovascular disease of rats in Exp. I
Experiment Groups
Ratio of Lipid Profiles
TC/LDL TC/HDL LDL/HDL
Control 1.41 ± 0.20
1)b2) 3.94 ± 0.91
N.S. 2.74 ± 0.88
N.S.
M2.5 1.80 ± 0.38
a 3.08 ± 1.10 1.87 ± 1.09
M5 1.82 ± 0.28
a 2.85 ± 0.61 1.62 ± 0.52
1)  Mean ± SD
2) Significantly different am ong groups by Duncan’s multiple range test at a=0.05 
level  after  one  way  ANOVA.
N.S.  no  significant  difference
Table 8. Food intakes, body weight and body weight gain of rats in Exp. II 
Experiment Groups Food Intakes
(g/4 wks)
Energy Intakes
(kcal/4 wks)
Final BW
(g)
BW Gain
(g/4 wks) FER EER
M5 59.1 ± 7.6
1)bc2) 277.9 ± 20.5
c 254.0 ± 35.0
a 150.0 ± 33.4
ab 2.51 ± 0.34
ab 0.54 ± 0.09
ab
M10 61.1 ± 10.8 
bc 285.2 ± 36.2
bc 272.3 ± 39.2
a 168.5 ± 40.7
a 2.74 ± 0.25
a 0.59 ± 0.11
a
HCM5 71.7 ± 4.8
a 311.2 ± 20.8
a 257.0 ± 20.9
a 153.3 ± 21.0
a 2.15 ± 0.35
b 0.49 ± 0.10
ab
HCM10 67.0 ± 5.9
ab 285.4 ± 25.1
bc 250.3 ± 21.6
ab 146.8 ± 24,1
ab 2.19 ± 0.30
b 0.51 ± 0.10
ab
HFM5 54.1 ± 6.6
c 306.6 ± 32.3
ab 237.6 ± 22.8
ab 134.1 ± 22.6
ab 2.47 ± 0.21
ab 0.44 ± 0.07
ab
HFM10 53.9 ± 4.7
c 297.9 ± 26.0
ab 219.9 ± 17.5
b 116.5 ± 19.4
b 2.17 ± 0.39
b 0.39 ± 0.07
b
Significant Factor
3) BB A ,  B
1)  Mean ± SD
2)  Significantly  different  among  groups  by  Duncan’s  multiple  range  test  at  a=0.05  level  after  one  way  ANOVA.
3)  A:  The  effect  of  seamustard 
B:  The  effect  of  dietary  energy  composition
AB:  The  effect  of  seamustard  and  dietary  energy  composition
N.S.  no  significant  difference
BW  body  weight
FER  (food  efficiency  ratio) = body  weight  gain/food  intakes
EER  (energy  efficiency  ratio) = body  weight  gain/energy  intakes
Table 9. Organ weights of rats in Exp. II  (g)
Experiment Groups Liver Spleen Kidney Adrenal gland Epidedymal Fat pad Gastrocnemius
M5 8.39 ± 1.87
1)a2) 0.55 ± 0.13
ab 2.19 ± 0.26
a 0.046 ± 0.024
a 2.01 ± 0.32
ab 2.58 ± 0.86
N.S.
M10 8.28 ± 2.22
a 0.62 ± 0.15
a 2.02 ± 0.80
a 0.027 ± 0.006
b 1.92 ± 0.23
ab 2.34 ± 0.72
HCM5 8.07 ± 0.55
a 0.53 ± 0.15
ab 1.89 ± 0.31
abc 0.026 ± 0.009
b 2.17 ± 0.39
a 2.39 ± 0.93
HCM10 7.52 ± 1.81
ab 0.55 ± 0.08
ab 1.66 ± 0.29
bc 0.033 ± 0.018
ab 1.77 ± 0.36
ab 1.93 ± 1.45
HFM5 6.95 ± 1.46
ab 0.46 ± 0.10
b 1.67 ± 0.17
bc 0.028 ± 0.006
b 1.69 ± 0.30
ab 2.51 ± 1.07
HFM10 6.16 ± 1.07
b 0.41 ± 0.05
b 1.50 ± 0.21
c 0.024 ± 0.006
b 1.51 ± 0.59
b 2.06 ± 0.58
Significant Factor
3) BB A
1)  Mean ± SD
2)  Significantly  different  among  groups  by  Duncan’s  multiple  range  test  at  a=0.05  level  after  one  way  ANOVA.
3)  A:  The  effect  of  seamustard 
B:  The  effect  of  dietary  energy  composition
AB:  The  effect  of  seamustard  and  dietary  energy  composition
N.S.  no  significant  difference
group. However, in the ratio of TC to HDL and the ratio of 
LDL to HDL, there were no significant differences among 
groups, even though the ratios tended to decrease according to 
seamustard level. 
Exp. II
The food intake, energy intake, body weight gain, food 
efficiency ratio (FER) and energy efficiency ratio (EER) of rats 
are shown in Table 8. Food intakes of high fat diet groups (HFM5 
& HFM10) were significantly lower (p<.05) than those of high 
carbohydrate diet groups (HCM5 & HCM10). Energy intake was 
the highest in HCM5 group and the lowest in M5 group; final 
body weight and body weight gain were the highest in M10 group 
and the lowest in HFM10 group (p<.05). FER was the lowest 
in HCM5 group, and EER was the lowest in HFM10 group, while 
both of FER and EER were the highest in M10 group. 
Conclusively, seamustard affected only body weight gain, while 
dietary energy composition affected both food intake and body 
weight gain of rats.
As shown in Table 9, the weights of liver and kidney of 
HFM10 group were significantly lower than those of the other 
groups (p<.05). Spleen weight of high fat diet groups (HFM5 
& HFM10) were significantly lower than those of M5 and M10 
groups (p<.05), and adrenal glands weight of HFM10 group was 
the lowest among groups. The weight of epididymal fat pads 
was the lowest in HFM10 group, but there were no significant 
differences in weight of gastrocnemius muscle among all groups. 
Consequently, dietary energy composition affected the weights 
of liver and kidney, but seamustard affected the weight of 
gastrocnemius.
As shown in Table 10, daily fecal weight and fecal lipid content 
did not show any significant difference among groups. Fecal 
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Table 10. Fecal and hepatic lipid and cholesterol contents of rats in Exp. II
Experiment Groups Fecal Weight*
(g)
Fecal Lipid
(g/g feces) 
Fecal Cholesterol
(mg/g feces)
Hepatic Lipid
(g/g tissue)
Hepatic Cholesterol
(mg/g tissue)
M5 12.75 ± 3.37
1)n,s. 0.116 ± 0.023
n,s.  6.32 ± 1.87
c2) 0.126 ± 0.039
n,s. 59.27 ± 7.63
n,s.
M10 21.50 ± 11.90 0.095 ± 0.014  8.07 ± 2.45
bc 0.100 ± 0.016 50.88 ± 15.45
HCM5 14.01 ± 5.01 0.175 ± 0.165  6.18 ± 1.89
c 0.118 ± 0.048 54.46 ± 32.03
HCM10 19.75 ± 5.44 0.116 ± 0.054  9.68 ± 0.51
ab 0.098 ± 0.020 37.23 ± 6.25
HFM5 16.16 ± 4.39 0.139 ± 0.084 11.56 ± 1.10
a 0.126 ± 0.030 55.94 ± 30.76
HFM10 18.50 ± 5.21 0.177 ± 0.062 11.56 ± 3.17
a 0.136 ± 0.046 41.51 ± 32.22
Significant Factor
3) ABA
1)  Mean ± SD
2)  Significantly  different  among  groups  by  Duncan’s  multiple  range  test  at  a=0.05  level  after  one  way  ANOVA.
3)  A:  The  effect  of  seamustard 
B:  The  effect  of  dietary  energy  composition
AB:  The  effect  of  seamustard  and  dietary  energy  composition
N.S.  no  significant  difference
* The  feces  were  collected  from  3  week  to  4  week  during  experimental  periods.
Table 11. Serum glucose concentration and lipid profile of rats in Exp. II 
Experiment Groups Serum Glucose 
Concentration (mg/dl)
Serum Lipid Concentration
TG (mg/dl) TC (mg/dl) LDL (mg/dl) HDL (mg/dl)
M5 118.63 ± 24.12
1)N.S. 25.84 ± 24.01
N.S. 64.31 ± 11.43
N.S. 36.16 ± 8.95
b2) 22.98 ± 3.43
ab
M10 116.33 ± 24.89 19.15 ± 9.41 60.66 ± 7.74 37.97 ± 4.89
b 18.87 ± 6.80
abc
HCM5 123.88 ± 21.35 17.72 ± 4.80 67.87 ± 8.62 39.93 ± 7.71
ab 24.39 ± 6.23
a
HCM10 114.46 ± 20.70 19.05 ± 10.80 63.62 ± 7.92 43.83 ± 5.82
a 15.98 ± 3.32
bc
HFM5 107.80 ± 13.09 13.74 ± 3.57 61.55 ± 4.50 42.74 ± 5.06
ab 16.06 ± 2.36
bc
HFM10 109.52 ± 28.75 15.27 ± 3.39 66.83 ± 3.65 50.13 ± 4.13
a 13.65 ± 6.42
c
Significant Factor
3) B AB
1)  Mean ± SD
2) S i g n i f i c a n t l y  d i f f e r e n t  a m o n g  g r o u p s  b y  D u n c a n ’ s  m u l t ip l e  r a n g e  test  at  a=0.05  level  after  one  way  ANOVA.
3)  A:  The  effect  of  seamustard 
B:  The  effect  of  dietary  energy  composition
AB:  The  effect  of  seamustard  and  dietary  energy  composition
N.S.  no  significant  difference
Table 12. The risk for cardiovascular disease of rats in Exp. II
Experiment Groups
Ratio of Lipid Profiles
TC/LDL TC/HDL LDL/HDL
M5 1.82 ± 0.28
1)a2) 2.85 ± 0.61
b 1.62 ± 0.52
b
M10 1.61 ± 0.20
abc 3.69 ± 1.40
b 2.37 ± 1.32
b
HCM5 1.73 ± 0.22
ab 2.88 ± 0.55
b 1.72 ± 0.51
b
HCM10 1.46 ± 0.10
bc 4.11 ± 0.89
b 2.87 ± 0.83
b
HFM5 1.45 ± 0.10
bc 3.90 ± 0.59
b 2.72 ± 0.58
b
HFM10 1.34 ± 0.15
c 6.10 ± 3.20
a 4.82 ± 3.05
a
Significant Factor
3) AB A A
1)  Mean ± SD
2) Significantly different among groups by Duncan’s multiple range test at a=0.05 
level  after  one  way  ANOVA.
3)  A:  The  effect  of  seamustard 
B:  The  effect  of  dietary  energy  composition
AB:  The  effect  of  seamustard  and  dietary  energy  composition
N.S.  no  significant  difference
significantly higher than that of HCM5 group. However, there 
were no significant differences in hepatic total lipid and cholesterol 
contents among groups. As a result, seamustard affected fecal 
weights and hepatic cholesterol contents, while dietary energy 
composition might affect fecal cholesterol excretion.
As shown in Table 11, the concentrations of glucose, 
triglyceride and total cholesterol (TC) in serum showed no 
significant differences among groups, even though serum glucose 
and triglyceride concentrations of high fat diet groups (HFM5 
& HFM10) tended to be lower than other groups. However, 
serum LDL-cholesterol (LDL) concentrations of these groups 
were higher than those of control diet groups (M5 & M10). 
Serum HDL-cholesterol (HDL) concentration of HFM10 group 
was the lowest among all groups. As a result, 10% seamustard 
level and high fat diet affected serum cholesterol profiles of rats 
undesirably. As shown in Table 12, the ratios TC/LDL of M10, 
HCM10, and HFM10 groups tended to be lower than those of 
M5, HCM5, and HFM5 groups, respectively. However, the ratios 
TC/HDL and LDL/HDL were not significantly different among 
groups, except those of HFM10 group. Extraordinarily in HFM10 
group, the risk for atherosclerotic cardiovascular diseases, the 
ratio of TC/HDL was the highest. From the results, it was 
observed that seamustard as a dietary fiber source might 
confer the risk for cardiovascular disease in high fat diets 
statistically.36 Seamustard, energy composition & blood lipid profiles
Discussion
Generally, it has been recognized that dietary fiber had 
numerous important physiological effects on the gastrointestinal 
tract, which might be attributed in large part to the viscosity 
or fermentability of the fiber sources. In upper gastrointestinal 
tract, an important attribute of fiber is its viscosity which may 
lead to delay in gastric emptying, interfere with or prolonged 
absorption of other nutrients, for example, cholesterol or glucose 
(Lupton & Trumbo, 2006). 
Viscous fibers, such as pectin, guar, oat bran and psyllium 
are considered to have a cholesterol-lowering effect (Fernandez, 
2001), a reducing hunger or weight loss (Birketvedt, 2000) as 
well as a protective effect against cardiovascular disease (Truswell, 
2002). The well-known physiological function of soluble viscous 
fiber is a LDL cholesterol-lowering effect (Anderson & Hanna, 
1999; Fernandez, 2001). 
In this study, there were no significant differences in fecal and 
hepatic cholesterol changes by seamustard consumption in control 
group. However, 10% seamustard level induced to increase fecal 
cholesterol excretion and to decrease hepatic cholesterol contents 
remarkably in high carbohydrate diet groups (Table 5, Table 10). 
From these results, it was expected that seaweeds containing 
soluble viscous fiber and some healthy components, might affect 
bile acid excretion to the intestine and affect the cholesterol 
metabolism at higher level in rats fed with high carbohydrate 
diet. 
Interestingly, seamustard at below 5% level in control group 
induced to decrease LDL-cholesterol (LDL) and to increase 
HDL-cholesterol (HDL). In contrast, 10% seamustard level 
induced to increase LDL of rats fed with high carbohydrate diet 
or high fat diet significantly compared to rats fed with control 
diet. Assessment of risk for coronary disease is usually done by 
measuring TC and LDL in blood as well as the ratios TC/LDL, 
TC/HDL or LDL/HDL. Elevated LDL is considered to be a major 
risk factor, and HDL-cholesterol is a major protective factor for 
cardiovascular diseases (Kritchevsky, 2006). It is reported that 
the risk for coronary disease may be high, especially when the 
ratio of TC/HDL is greater than 4:1. It may be optimal when 
that ratio is 3.5:1 or less (Wardlaw & Smith, 2009). In this study, 
the TC/HDL ratios of all diet groups were similar or lower than 
4:1, except HFM10 group (6:1) in which rats were fed high fat 
diet with 10% seamustard powder as fiber source (Table 7, Table 
12). From the results, it was observed that the higher was the 
seamustard level, the worse serum lipid profile was in high fat 
diet especially. 
There were no significant changes in serum triglyceride as well 
as glucose concentration among all groups. It has been reported 
that if high carbohydrate diet was also a high fiber diet, fasting 
triglyceride level in blood would be reduced while it is usually 
increased in high carbohydrate and low fiber diet (Anderson, 
2000). Total fiber of seamustard powder is about 14.2 g per 100 
g edible portion (National Rural Resources Development Institute, 
2006). Therefore, dietary fiber levels in diets of Exp. I groups 
were 5% (cellulose) in control diet, 2.85% (cellulose+seamustard 
fiber) in M2.5 group and 0.71% (seamustard fiber) in M5 group, 
respectively. The seamustard fiber levels in diets in Exp. II 
groups were 0.71% in M5, HCM5, and HFM5 groups and 1.42% 
in M10, HCM10, and HFM10 groups. According to replacement 
of cellulose by seamustard powder partially or completely, 
substantial dietary fiber level was dramatically reduced. From 
these results, it could be speculated that seamustard effect on 
body weight gain or serum lipid profiles relied on its soluble 
fiber, alginic acid and/or other components. Seaweeds contain 
much  β- carotene, iodine, or a bioactive components such as 
fucoidan. Nowadays, these substances are known to be effective 
for preventing chronic diseases such as obesity, diabetes mellitus, 
atherosclerosis as well as cancer. In fact, interaction of both 
seamustard intake and dietary energy composition resulted in 
significantly different effects on body weight and HDL-cholesterol 
between high fat diet and high carbohydrate diet.
Sometimes the reduction of LDL level implied lowering levels 
of circulating carotenoids and vitamin E because they are 
transported in LDL (Noakes et al., 2002). Olistat, a chemically 
synthesized derivative of lipostatin, directly inhibited the lipase 
activity and resulted in the suppression of triglyceride digestion 
by around 30%, and thus increasing fecal elimination of fat, and 
therefore overall effects resulted in a 5 % to 10% weight loss 
and improved total-, LDL- and HDL-cholesterol levels without 
significant declines in circulating vitamin A, vitamin D, vitamin 
E and β-carotene (Hutton & Fegusson, 2004). 
Conclusively, the present study suggested that seamustard 
might be more effective for body weight control in high fat diet 
than in high carbohydrate diet, but not for improving blood lipid 
profiles. Even though still remain the difficulties and research 
limitations to generalize this suggestion. In the future, more 
well-designed epidemiologic researches would be needed to 
investigate the beneficial and/or undesirable effects of seamustard 
consumption on modern population living under the global 
environments.
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